Press release
Corporate Press
May 7, 2010

Evonik Showcases Sustainability and Innovation at NYSCC Suppliers’ Day 2010

Introducing Inspiring Active Ingredients & Natural, Biodegradable Cosmetic Raw Materials The Personal Care product line of Evonik is introducing a unique and comprehensive portfolio of innovative personal care products and technologies to North America at the 2010 NYSCC Suppliers’ Day in Edison, New Jersey, May 11-12 (Booth No. 204).

Following the trend of sustainability, the business line is providing a broad portfolio of natural and biodegradable products, such as the new purely-vegetable-based emulsifier TEGO® Care PSC 3. Applicable for a wide pH range, it allows “green” preservation with organic acids. Its application profile combines mildness, robustness, versatility, and cost-efficiency with smooth and caring aesthetics.
As environmental awareness grows, more focus is being placed on new and effective ways to reduce emissions and conserve energy in the production process. In response to this growing need, Evonik
has become the only supplier to commercialize biotechnologicallyderived cosmetic esters. This production route uses 60 percent less energy than conventional chemical processes and reduces the
formation of pollutants by up to 88 percent. A prime example of these products is TEGOSOFT® OER, a new enzymatically produced, vegetable-based emollient with caring properties and a smooth, non-oily skin feel. It is easy to formulate and can be incorporated into both oil-in-water and water-in-oil systems.

Anti-aging products now constitute a megatrend, and in response Evonik has launched a novel active ingredient for such applications. Within the anti-aging market segment, hyaluronic acid has been widely-used in many product formulations. With this market standard in mind, the product line Personal Care of Evonik decided to launch another product based on its very pure hyaluronic acid. To the business line’s actives range, which included moisturizing HyaCare® and the tight junction strengthening HyaCare® 50, Evonik has added a topical wrinkle smoother – HyaCare® Filler CL. It is based on a unique cross-linked polysaccharide made from fermentation-derived hyaluronic acid.

HyaCare® Filler CL contributes to the reduction of facial wrinkles and fine lines, and increases the elasticity of the skin. Because of its high water-binding and strong short-term moisturization properties, HyaCare® Filler CL effectively supports skin hydration. It can be used for all anti-aging applications where an instant effect as well as moisturization is desired.

To broaden its selection of botanically-based ingredients and formulation possibilities, Evonik has added another plant extract to its portfolio. TEGO® Xymenynic is a highly purified phytochemical
compound extracted from sandalwood seeds. It relies on the efficacy of xymenynic acid to boost cellular detoxification mechanisms and to alleviate adverse symptoms of skin inflammation. The beneficial effects provided by TEGO® Xymenynic include increased skin firmness and a minimized appearance of

For more information, contact:
Lauren Kjeldsen
Director, Personal Care
Evonik Goldschmidt Corporation
Phone: 804-452-5624

About Evonik

Evonik Industries is the creative industrial group from Germany which operates in three business areas: Chemicals, Energy and Real Estate. Evonik is a global leader in specialty chemicals, an expert in power
generation from hard coal and renewable energies, and one of the largest private residential real estate
companies in Germany. Our strengths are creativity, specialization, continuous self-renewal, and
Evonik is active in over 100 countries around the world. In its fiscal year 2008 about 41,000 employees
generated sales of about €15.9 billion and an operating profit EBITDA of about €2.2 billion.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating
environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the
forecasts, expectations or statements contained in this release.